[Therapeutic management of duodenal ulcer except in emergency: eradication of Helicobacter pylori].
Lamouliatte
H
H
Service de Gastroentérologie, Hôpital Saint-André, Bordeaux.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology / Q000517:prevention & control; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology / Q000517:prevention & control; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D010438:Peptic Ulcer Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D012008:Recurrence
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists
Prise en charge thérapeutique de la maladie ulcéreuse duodénale en dehors de l'urgence: éradication d'Helicobacter pylori.